Role of Smartphone Stroke App to reduce post stroke complications among stroke patients

Not Applicable

Completed

• Conditions: Health Condition 1: null- BEDRIDDEN STROKE PATIENTS AND THEIR CAREGIVERSHealth Condition 2: G819- Hemiplegia, unspecified

• Registration Number: CTRI/2017/08/009267
• Lead Sponsor: Ashok Kumar

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-04-20
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 166

Inclusion Criteria

1.All stroke patients >=18 years of age.

2.Recent ( <1month) acute ischemic/haemorrhagic/undifferentiated stroke.

3.Stroke survivors with significant residual disability (requiring help from another person for everyday activities)/bedridden patients (mRS >3).

4.The caregivers are willing and able to provide care to the patients after discharge.

5.The caregivers / patients must have a smartphone/tablet with internet facility and should be competent as well as willing to use an app as a health care tool (For Phase Ib (Pilot phase) and Phase II).

6.Expected to survive to discharge from hospital with a reasonable expectation of 6 month survival (i.e. not palliative, no evidence of widespread cancer etc.)

7.Stroke survivors/caregivers who will provide informed written consent.

(Subjects will only be recruited if they or their legally acceptable representatives (LARs) are willing to provide a written informed consent to participate in the study.)

Exclusion Criteria

1.Stroke survivors with no caregiver or hired caregiver or illiterate caregiver,

2.Caregiver who is not competent enough to use MAPSS as per the investigators judgment {For Phase Ib (Pilot phase) and Phase II}.

3.Stroke survivors who localized in poor network connectivity area {For Phase Ib (Pilot phase) and Phase II}.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Development of bed-sores in a patient with mRS 3 at discharge from the hospital with in first 3 months is taken as surrogate marker as well as primary outcome of the study. <br/ ><br> <br/ ><br>Co-primary outcomes: <br/ ><br>i.Development of other complications eg. aspiration pneumonia, catheter related UTIs, contracture frozen shoulder, DVT (incidence rates for all) <br/ ><br>ii.Caregiver stress index (CSI) score. <br/ ><br>iii.Quality of life of patients (score) <br/ ><br>Timepoint: at 3 months and 6 months after stroke development. <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
i.Functional status of the patients / Disability (mRS score). <br/ ><br>ii.Number of Patientsâ?? hospital visits /hospitalization. <br/ ><br>iii.Skills / Knowledge / Practice/Opinions (score) <br/ ><br>iv.ADL score. <br/ ><br>Timepoint: 3 MONTHS